Biodefense Market in Asia Pacific would register a CAGR of 7% during 2020-2026

Published Date: 3-Feb-2021

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

According to a new report Asia Pacific Biodefense Market, published by KBV research, the Asia Pacific Biodefense Market would witness market growth of 7% CAGR during the forecast period (2020-2026).

The China market dominated the Asia Pacific Biodefense Market by Country in 2019, growing at a CAGR of 4.8 % during the forecast period. The Japan market is experiencing a CAGR of 7.9% during (2020 - 2026). Additionally, The India market is anticipated to witness a CAGR of 8% during (2020 - 2026).

The Anthrax market dominated the Malaysia Biodefense Market by Product in 2019, thereby, achieving a market value of $64 million by 2026. The Smallpox market would showcase a CAGR of 7.6% during (2020 - 2026). Additionally, The Botulism market is estimated to grow at the highest CAGR of 10.2% during (2020 - 2026).

Full Report: https://www.kbvresearch.com/asia-pacific-biodefense-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Xoma Corporation, Altimmune, Inc., Emergent BioSolutions, Inc., Dynavax Technologies Corporation, SIGA Technologies, Inc., Elusys Therapeutics, Inc., Ichor Holdings, Ltd., Cleveland BioLabs, Inc., Bavarian Nordic A/S and Alnylam Pharmaceuticals, Inc.

Asia Pacific Biodefense Market Segmentation

By Product

  • Anthrax
  • Smallpox
  • Botulism
  • Radiation/nuclear
  • Other Products

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled

  • Xoma Corporation
  • Altimmune, Inc.
  • Emergent BioSolutions, Inc.
  • Dynavax Technologies Corporation
  • SIGA Technologies, Inc.
  • Elusys Therapeutics, Inc.
  • Ichor Holdings, Ltd.
  • Cleveland BioLabs, Inc.
  • Bavarian Nordic A/S
  • Alnylam Pharmaceuticals, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Biodefense Market Related Reports:

Global Market

North America Market

Europe Market

LAMEA Market

Request a Free Sample Copy


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.